Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from China Shineway Pharmaceutical Group Limited ( (HK:2877) ) is now available.
China Shineway Pharmaceutical Group Limited announced a first interim ordinary cash dividend of RMB 0.36 per share for the fiscal year ending December 31, 2025. The dividend will be paid in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.07, with a payment date set for May 20, 2025. This announcement reflects the company’s financial health and commitment to returning value to its shareholders, potentially enhancing its attractiveness to investors.
More about China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited operates in the pharmaceutical industry, focusing on the production and distribution of traditional Chinese medicine products. The company is known for its range of herbal medicines and health supplements, catering primarily to the Chinese market.
YTD Price Performance: -10.16%
Average Trading Volume: 1,103,118
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$6.4B
Learn more about 2877 stock on TipRanks’ Stock Analysis page.